CLEAR Care Companion Application

University of Michigan Rogel Cancer Center

Status: Completed

Conditions: Bladder Cancer; Radical Cystectomy

Treatments: Behavioral: CLEAR Care Companion (CC) application

Study type: Interventional

Funder types: Other

Identifiers

NCT05578898

UMCC 2021.077

HUM00201652 (Other Identifier)

Details and patient eligibility

About

Hospital readmissions are common after major cancer surgery, leading to poorer patient outcomes, increased mortality and additional costs. In this study, Clinical and Engineering Approaches to Readmission (CLEAR) Care Companion Application, investigators aim to utilize a smartphone application that tracks concerning postoperative symptoms and provides educational interventions to determine if this can minimize delays in communication between patients and medical providers, increase patient satisfaction with the care received, and reduce or lessen the severity of readmissions.

Full description

Patients complete clinically meaningful questions and validated questionnaires pertaining to physiological and psychological symptoms that serve as early indicators of readmission, with the aim to improve experience by empowering patient to be active participants in their recovery, identify complications early to minimize morbidity and reduce overall readmissions.

The study has the following three objectives: (1) Assess patient engagement with the CLEAR Care Companion application for patients that have undergone radical cystectomy (2) Measure patient experience with the application and its effect on satisfaction with overall care (3) Evaluate the effect of the application on case complexity (readmission intensity) and overall readmission rates.

Enrollment: 28 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients undergoing a radical cystectomy with reconstruction through GU Oncology Clinic
• Patient at the University of Michigan (Michigan Medicine)
• Access to compatible smartphone or tablet device

Exclusion criteria

• Non-English speaking patients
• Patients without access to a smart phone or tablet with internet capacity

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

28 participants in 1 patient group

CLEAR CC

Experimental group

Description:

Patients use CLEAR CC application with Smartphone or Tablet

Treatment:

Behavioral: CLEAR Care Companion (CC) application